Despite perceived safety and popularity of SSRIs and other antidepressants, studies suggest usage can bring dangerous and understated side effects, especially for adolescents and young adults. In 2004, after a thorough review of data, the Food and Drug Administration (FDA) adopted a “black box” warning label on all antidepressant medications to alert the public for potential risks of increased suicidal thoughts in children and adolescents taking antidepressants.